Multiple regression models adjusted for age, gender, history of underlying disease (diabetes mellitus, hypertension, dyslipidemia, cardiovascular disease, atrial fibrillation), and smoking were also run to predict the effects of AST/ALT, ALP/ALT, and AST/ALP separately on three-month mRS. This evidence concerns the gene GPT and metabolic syndrome.